Regulatory Services Beyond Cosmetics Home Other Regulatory Services Your Compliance Partner Beyond Cosmetics Biorius extends its regulatory and scientific expertise to a wide range of…

In August 2024, Canada launched a PFAS data collection initiative under the Chemicals Management Plan. Companies handling listed PFAS in 2023 must report details—including quantities and product use—by January 29, 2025. Cosmetics and packaging containing PFAS may fall under the scope.

In the U.S., over-the-counter (OTC) drugs must include a standardized Drug Facts label—required by the FDA—to ensure clarity, safety, and informed consumer use. Biorius supports cosmetic and personal care brands by reviewing formulas and preparing compliant Drug Facts for various OTC categories, from sunscreen to oral care.

Cosmetics check – Complete Guide Home Cosmetics check – Complete Guide A “cosmetics check” is essential for ensuring your cosmetic products are safe, compliant, and…

Understanding the Role of the Responsible Person (RP) in Cosmetic Regulations Home Understanding the Role of the Responsible Person (RP) in Cosmetic Regulations Navigating the…

Biorius Information Letter 128: Update of the Canada Cosmetic Ingredient Hotlist   Health Canada has updated the Canada Cosmetic Ingredient Hotlist. It includes a part…